INS and Alzheimer disease: Interestingly, rapamycin (a well-known mTOR inhibitor) (Caccamo et al., 2010; Spilman et al., 2010) mitigates AD pathology and cognitive dysfunctions in mice fed with an insulin resistance-inducing diet (Orr et al., 2014).